Tumor Ablation Market Insights: Growth Factors, Market Drivers, Segmentations, Key Players, Analysis & Forecast by 2023

Tumor Ablation Market: Information by Technology (Radiofrequency, Microwave), Treatment (Surgical, Percutaneous), Application (Liver cancer, Lung cancer), By End User (Hospital, Surgical and Ablation Centers) - Global Forecast Till 2023

Market Highlights:
The Global Tumor Ablation Market accounts for USD 363.1 million in 2017 and expected to register healthy CAGR ~12.8% during the forecast period. Tumor Ablation Market is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the Tumor Ablation Market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing research and development in healthcare and advancement in technologies. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities.

The cost containment policies by various governments, stringent regulatory environment for product approval, and scarcity of experts are likely to hinder market growth during the forecast period.

 
Regional Analysis:
The American market is expected to dominate the global Tumor Ablation Market during the forecast period due to the increase in number of cancer cases along with growing geriatric population, adoption of advance technology in healthcare, and favorable reimbursement and regulatory authorities. The European market is expected to be the second-largest due to increased pool of cancer patients and rising healthcare expenditure. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population in countries such as India and China, government initiatives and investment for the development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global Tumor Ablation Market.

Browse Complete Report :https://www.marketresearchfuture.com/reports/tumor-ablation-market-7139

Segmentation:
The Global Tumor Ablation Market has been segmented on the basis of technology, treatment, application, and end-user.

The technology segment has been segregated into Radiofrequency, Microwave, Irreversible Electroporation, Cryoablation and others.

On the basis of treatment, the market has been classified as surgical, percutaneous and laparoscopic.

The Tumor Ablation Market, by application, has been segmented into Liver cancer, Lung cancer, Breast cancer, Bone cancer, Prostate cancer and others.

End-user segment is divided into hospitals, surgical and ablation centers, and research institute.

Key Players:
Some of the key players in the global Tumor Ablation Market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Biotronik, Galil Medical, Inc, Misonix Inc., and Covidien PL

Surgical Microscopes Market Detailed Analysis, Growth Factors, Top Key Companies, Trends and Developments, 2018-2023

surgical microscopes market research report: by type (on casters, wall mounted, and others), By application (ophthalmology, ENT surgery, dentistry, and others) By end user (hospitals, physician’s clinic, and others)- Forecast Till 2023

Market Highlights:
Global Surgical Microscopes Market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period.

Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period.

On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent.

Regional Analysis:
Geographically, the Americas is anticipated to dominate the global surgical microscopes market owing to the, rising number of the neurosurgeries, spinal surgeries, and ophthalmic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have positively affected the growth of the American market. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical microscopes market in this region.

Europe is expected to hold the second largest market share in the global surgical microscopes market. The market growth in this region is majorly attributed to the presence of large number of market players in the region and increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical microscopes market owing to increased rate in neurosurgeries in the Asian region. Moreover, the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical microscopes market during the forecast period.

 Browse Complete Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065

Segmentation:
The Global Surgical Microscopes Market. has been segmented into type, application and end user.

Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products.

Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment.

Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa.

Key Players:
Some of the prominent players in the global surgical microscopes market are Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc.

Genitourinary Urinery Drugs Market Segmentation, Dynamics, Market Size, Supply & Demand, Competition & Companies, Drivers, Restraints and Technology

Genitourinary Urinery Drugs Market: Information by Disease (Urinary Tract Infections, Erectile Dysfunction, Hematuria, and Others), Product (Urological, Hormonal Therapy, and Others), End-User(Hospitals, Super specialty clinics) — Global Forecast till 2023

The global Genitourinary Urinery Drugs Market may find better growth prospects with surging demand and expanding healthcare. Genitourinary drugs are expected to dominate a large part of the pharmaceuticals market. Genitourinary drugs refer to pharmaceuticals used to treat diseases of the urinary and genital organs such as kidneys, ureters, bladder, urethra, and others. The large spectrum of diseases originating from these organs drives a large market for genitourinary drugs.

According to Market Research Future (MRFR), the global Genitourinary Urinery Drugs Market accounts for a valuation of USD 28,200 MN in 2018. In its recently published analysis, MRFR also asserts that the market would register a CAGR of over 1.65% over the assessment period (2018-2023). Growing demand for genitourinary drugs owing to growing prevalence of genitourinary diseases and expanding healthcare are the key driving force behind the substantial market demand. 

According to the Centers for Disease Control and Prevention, urinary tract infections are the most common infection demanding medical care and causing almost 9.6 million ambulatory care visits. The economic burden of urinary tract infections is almost US$ 2 Bn annually. Urinary tract infections also are the leading cause of antibiotic use in the U.S.

Surging healthcare expenditure, growing world population, and growing per capita income can trigger better growth for the market. The expansion of healthcare infrastructure, including the dramatical increase in the number of hospitals and clinics, can bolster the growth of the market. The growing number of geriatrics is another driver of the market. According to the Department of Economic and Social Affairs of the U.N. almost 12.4% population in the Asian countries are more than 60-year-old.

Global Genitourinary Urinery Drugs Market – Segments

The report contains four dynamics to widen the scope of understanding,

By Disease          : Urinary Incontinence & Overactive Bladder, Urinary Tract Infections, Genitourinary Cancer, Kidney/Renal Cancer, Cervical Cancer, Bladder Cancer, Interstitial Cystitis, Sexually Transmitted Diseases, Ovarian Cancer, Hematuria, Prostate Cancer, among others.

By Product          : Urologicals, Hormonal Therapy, Gynaecologicals, Anti-Infectives, among others.

By End-use         : Hospitals, Clinics, Specialty Centers, and others.

By Regions   : the APAC (Asia Pacific), North America, Europe, and the Middle East and Africa.

Browse Complete Report :https://www.marketresearchfuture.com/reports/genitourinary-drugs-market-6802

Global Genitourinary Urinery Drugs Market – Regional Analysis

North America dominates the global Genitourinary Urinery Drugs Market with the largest market share led by the U.S. As opined by the National Kidney Foundation, urinary tract infections account for almost 10 million physician visits every year and roughly, 20% females suffer from urinary tract infections at least once during their lifetime. Factors such as the enactment of the Hospital Readmissions Reduction Program (HRRP) is expected to drive the growth of the North America market. According to the CDC, 75% of infections of the urinary tract in hospitals are associated with the use of urinary catheters.  The growing use of urinary catheters, which account for 15-25% of hospitalized patients is a large driver of the Genitourinary Urinery Drugs Market.

The Genitourinary Urinery Drugs Market in Europe is growing rapidly. The proliferating healthcare industry and greater rates of hospital admissions in the region are expected to boost market growth.

The Asia Pacific Genitourinary Urinery Drugs Market is projected to become the largest market globally owing to expanding economy and per capita income. Growing pharmaceutical manufacturing and a large population drive the growth of the Asia Pacific market.

The MEA (Middle East & Africa market) is expected to account for a large growth owing to low penetration and large potential growth. However, poor economic and political conditions are hampering the growth of the market.

Global Genitourinary Urinery Drugs Market – Competitive Landscape

The Genitourinary Urinery Drugs Market appears to be fragmented and highly competitive due to the presence of several big and small players. The market is commoditized and major drug classes are generic. The market has also suffered a loss of exclusivity owing to patent expiration.

Thus, there is a lot of overcapacity in the market, especially in the antibiotics sector. China has a large antibiotics API manufacturing capacity which is idle resulting in large fall in prices. Many players have exited the antibiotics manufacturing which is a downside of the market.

Major Players:

Players leading the global Genitourinary Urinery Drugs Market include Abbott, Astellas Pharma Inc., AstraZeneca, Pfizer Inc., Eli Lilly and Company, Genentech, Inc., Immunex Corp., GlaxoSmithKline plc., Ionis Pharmaceuticals, Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, Antares Pharma, Bayer AG, among others.

Industry/ Innovation/ Related News:

July 17, 2019 ---- The Food and Drug Administration approved Recarbrio of Merck & Co., Inc., which is a combination of imipenem, cilastatin, and relebactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. While imipenem-cilastatin, has been approved by the FDA before, relebactam, is a new beta-lactamase inhibitor antibiotic.

FDA’s under its Qualified Infectious Disease Product (QIDP) designation granted Recarbrio approval based on clinical studies. The QIDP designation is granted to antibiotic drugs used in the treatment of serious infections.

Urgent Care Apps Market 2018-2023: Market Segments, Dynamics, Size, Supply & Demand, Current Trends and Forecast

Urgent Care Apps Market Research Report by Type (Emergency care triage apps, In-hospital communication & collaboration apps, and Post-hospital apps), Clinical Area (Trauma, Stroke, Cardiac conditions, and Others), and Region (America, Europe, APAC, RoW)-Global Forecast to 2023

Market Synopsis

The global Urgent Care Apps Market was valued at USD 314.2 million in 2017 and can expect revenues of USD 2597.8 Mn by the end of 2023, says Market Research Future (MRFR). MRFR perceives the market to progress at a tremendous CAGR of 42.20% during the forecast period (2018-2023).

Market Research Future (MRFR) has launched a new release on the Global Urgent Care Apps Market. The report talks about the global urgent care apps market’s possible growth trajectory over the forecast period in detail on the basis of a detailed study of the market’s historical growth trajectory and current prospects. According to the report, the global urgent care apps market is expected to grow to a valuation of USD 2,597.8 million by 2023, rising from a value of just USD 314.2 million in 2017.

The market is expected to exhibit a staggering 42.20% CAGR over the forecast period. The report talks about the major segments of the global urgent care apps market in order to familiarize the readers with the granular internal structure of the market. The key drivers and restraints affecting the global urgent care apps market’s growth are also analyzed in the report in detail to familiarize readers with the factors likely to leave a lasting impact on the market in the coming years. Key players in the global urgent care apps market are also studied in the report to acquaint readers with the competitive dynamics of the market.

Urgent care apps have emerged quite recently in the healthcare sector but have grown in popularity rapidly due to the significant advantages they present in terms of patient engagement, time saving, and cost saving. Urgent care apps have become popular as they allow patients to skip the long wait times in hospitals in cases of emergency. They also help patients reduce their healthcare expenditure by allowing them to reduce their ER costs. The growing preference for personalized medicine is also likely to drive the demand for urgent care apps, as personalized information can be filled in the apps to suit each specific user.

The growing use of smartphones around the world has fueled the adoption of urgent care apps in recent years. A large number of smartphone users consider their smartphone as an important tool in gathering healthcare-related information, which has driven the adoption of urgent care apps. Conversely, the relatively low spread of high-speed mobile internet in underdeveloped countries has emerged as a significant restraint against the global urgent care apps market, as urgent care apps require high-speed internet to be used to their full capacity.

Segmentation:

The Global Urgent Care Apps Market is segmented on the basis of type, clinical area, and region.

By type, the global urgent care apps market is segmented into emergency care triage apps, in-hospital communication and collaboration apps, and post-hospital apps. The post-hospital apps segment is further sub-segmented into medication management apps, care provider communication and collaboration apps, and rehabilitation apps.

By clinical area, the global urgent care apps market is segmented into trauma, stroke, cardiac conditions, and others.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677

Regional Analysis:

Regionally, the Global Urgent Care Apps Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is likely to remain the leading contributor to the global urgent care apps market over the forecast period, driven by the growing adoption of urgent care apps in North America. The North American market is rife with high-tech solutions for common problems, including the use of urgent care apps. The widespread availability of high-speed internet in North America has allowed ubiquitous use of urgent care apps, with the rising smartphone usership further driving the market over the coming years. The growing prevalence of diseases in the Americas is also likely to lead to growth of the urgent care apps market in the region. Europe is also a leading market for urgent care apps, for similar reasons.

Asia Pacific is likely to exhibit robust growth in the global urgent care apps market over the forecast period due to the growing smartphone ownership and rapid development of the healthcare sector in the region.

Competitive Landscape:

Leading players in the global urgent care apps market include Argusoft, TigerConnect, PatientSafe Solutions, Twiage, Alayacare, Allm, Siilo, Pivot Design Group, Pulsara, Johnson & Johnson, Forward Health, Imprivata, Vocera Communications, Voalte, and Hospify.

Steam Autoclave Market : Information, Figures and Analytical Insights 2018 – 2023

 Steam Autoclave Market Research Report by Product (Table Top, Vertical, Horizontal, and Other), Technology (Gravity Displacement, Pre-vacuum and Other), End-User (Hospital & Clinics, healthcare organizations, and Other), Application (Medical, Dental, and Other), and Region-Global Forecast till 2023

Global Steam Autoclave Market: Drivers & Trends

The presence of key manufacturers of the steam autoclave devices is intensifying the competition among them, which is taking the global steam autoclave market to surge at a considerable level. The surgical procedures are growing owing to the rise in the chronic diseases that needs proper treatments. Therefore, the patient base is increasing in this case, especially in the developing countries owing to the proliferation of population in this region. These factors above are evenly propelling the adoption of the steam autoclave and which in turn, is boosting the growth of the steam autoclaves market.

Market Insights

According to the reports published by Market Research Future Reports, the global Steam Autoclave Market is probable to nurture significantly as it held a valuation of USD 1.78 billion in 2017 and is projected to register at a CAGR of 8.9% by 2023. Steam autoclaves are used for sterilization purposes where the process is non-toxic and inexpensive. 

Apart from this, the rising patient-centric approach and efforts are taken to reduce several side-effects and other infections, which in turn, are propelling adaptation of the steam autoclaves. Thus, these factors are also contributing to the best of it in the growth of the global steam autoclaves market. Also, the introduction of technologically advanced, which has E-beam and gamma irradiation are also influencing the growth of the global steam autoclave market on the positive note. Additionally, product flexibility and low cost of new products are probable to support the growth of the market.

As per the research, the growth of the steam autoclaves market is also gaining traction owing to the presence of strict regulations to ensure the safety of the patients and the growing presence of advanced healthcare facilities. 

Market Segmentation

According to the MRFR reports, the global steam autoclave market has been segmented into product type, technology, end user, and application.

By the mode of product type, the market has been segmented into the tabletop, vertical, horizontal, floor standing, and high pressure.

By the mode of technology, the market has been segmented into gravity displacement, pre-vacuum, and steam flush pressure pulse.

By the mode of technology, gravity displacement segment is expected to have the largest share of the market owing to its easy usage features and obstacle-free penetration. Wherein, pre-vacuum technology is predicted to cultivate at the fastest CAGR owing to the rising demand for the technology and high effectiveness in sterilizing porous substances.

By the mode of end user, the market has been segmented into hospitals & clinics, healthcare organizations, academic & research institutes, and other end users.

By the mode of application, the market has been segmented into medical, dental, laboratory, and others.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/steam-autoclave-market-6645

 

Regional Outlook

Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The steam autoclave market in the Americas is estimated to lead the global steam autoclave market owing to a rising number of research organizations in the region and increasing investments in healthcare.

Whereas, Europe is expected to own the second largest position in the global steam autoclave market. The market growth is attributed to the well-developed healthcare infrastructure.

Whereas, the steam autoclave market in the Asia-Pacific region is expected to be the fastest growing region owing to the ever-increasing amount of hazardous industrial and medical waste as well as increasing healthcare expenditure by the government.

Furthermore, the Middle East & Africa has the least share of the market owing to a well-developed healthcare sector, and growing government initiatives for the healthcare sector.

Key Players

In the reports of Market Research Future Reports, here are the names of some of the top market players. They are Belimed, BMM Weston Ltd., Getinge AB, LTE Scientific Ltd, PHC Corporation, Priorclave Ltd., Tuttnauer, STERIS plc, Astell Scientific, ZIRBUS technology GmbH, Accumax India, Consolidated Sterilizer Systems, MATACHANA GROUP, Sterigenics International LLC, Mar Cor Purification Inc. are some of the key players in the global steam autoclave market.

Sinus Dilation Devices Market Size, Growing Growth Opportunities, Driving Factors With Top Players 2020

Sinus Dilation Devices Market Research Report by Product (Sinus Stents, Balloon Dilation, Endoscope), Procedure (Hybrid Sinus Dilation), Patient Type (Pediatric, Adults), End-User (Hospitals, ENT Clinics, and Others)-Global Forecast till 2023

Market Analysis

The global Sinus Dilation Devices Market is expected to register a 8.1% CAGR during the forecast period of 2018 to 2023 and grow to valuation of USD 5,778 Mn by 2023 end reported Market Research Future (MRFR).

The clinical condition of inflamed sinus cavities present around the nasal cavity that obstructs the natural draining mechanism of the nose is called sinusitis. The sinus dilation devices aids in relieving the sinus cavity opening and eliminating the drainage problem. Acute sinusitis is triggered due to cold and allergies, whereas, bacterial invasion results in chronic sinusitis. The increase in cases of chronic sinusitis due to languid immunity of people is likely to increase the demand for sinus dilation device. Technical advancement is boosting the adoption of sinuplasty (sinus dilation), among patients, over traditional sinusitis surgery method. These are the market dynamics expected to drive the global sinus dilation device market. On the flip side, challenges like drugs preference over surgeries and lack of trained otolaryngologists are anticipated to impede the market escalation.

Segmental Overview

MRFR in its report encompasses all the factors influencing the global sinus dilation devices market. The segmental analysis of the market offers a clear understanding of the sinus dilation devices market. Hence, the global sinus dilation devices market study is segmented by product, procedure, by patient type and end-user.

On the basis of product, the sinus dilation devices market has been segmented into sinus stents, balloon dilation, endoscope, functional endoscopic sinus surgery (FESS) instruments set, and handheld instruments. The endoscope segment has been further narrowed down to rhinoscopy and sinoscopy. The drug eluting feature of the sinus stents, resists inflammation and scarring, hence, makes implantation extremely feasible for patients. Owing to the benefits of the stents the sinus stent segment is anticipated to register the highest CAGR in the upcoming years.

On the basis of procedure, the sinus dilation devices market has been segmented into hybrid sinus dilation procedure, standalone sinus dilation procedures, and others. Advancements in medical infrastructure is encouraging patients to opt sinus surgeries. The sinus dilation procedures segment is expected to gain traction for generating the largest revenue due to an increase in the number of patients availing for complex sinus surgeries. On the basis of patient type, the sinus dilation devices market is segmented into pediatric and adults. On the basis of end-user, the sinus dilation devices market is segmented into hospitals, ENT clinics, diagnostic centers, research centers, and others. 

Browse Complete Report: https://www.marketresearchfuture.com/reports/sinus-dilation-devices-market-6644

 

Regional Insights

The demographic analysis of the sinus dilation devices market has been segmented into North America, Europe, Asia Pacific, The Middle East and Africa, and Rest of the World (RoW).

In 2017, the Centers for Disease Control and Prevention data showed that 11.0% of the United Nations population were diagnosed with sinusitis. Hike in the suffering percentage has been observed over time in the region. This is creating a boundless scope for the key players in the regional market to invest in research and developmental activities to provide effective treatment to the patients. Hence, these factors are anticipated to drive the North American market growth, thereby, allowing the region to maintain its dilation devices market hegemony in the world. The second largest region after North America to grow to the highest market valuation in the assessment period is Europe, predicts MRFR. The increase in cases of sinusitis coupled with the presence of nasal polyp in patients is demanding proper medical attention. This is expected to drive the regional sinus dilation devices market proliferation.

The Asia Pacific region is likely to experience the fastest sinus dilation devices market growth. Technical advancement and patients opting for sinus dilation are expected to augment the regional market.

Although, the Middle East and African regional sinus dilation devices market growth is stationary. The increase in healthcare awareness and initiative taken by governments, in these regions, working towards the medical infrastructure development can impel the market growth in the region. 

Key Players 

MRFR listed the noteworthy companies operating globally in the sinus dilation devices market. They are Sklar Surgical Instruments (US), Accurate Surgical & Scientific Instruments(USA), Bausch & Lomb Incorporated (US), Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), Olympus Corporation (Japan), Meril Life, Sciences Pvt. Ltd. (India), SinuSys Corporation (US), Jilin Coronado Medical Ltd. (China), and others.

Wound Care Biologics Market Overview, Dynamics, Supply & Demand, Analysis & Forecast by 2023

Wound Care Biologics Research Report: Information by Product Type (Biological Skin Substitutes, Topical Agents), by Wound Type (Surgical and Traumatic Wounds, Diabetic Foot Ulcer, Pressure Ulcers), End User (Hospitals, Clinics)—Forecast till 2023

The global Wound Care Biologics Market stood at USD 1.20 Bn in 2017 and is touted to expand at a CAGR of 9.9% over the forecast period of 2018-2023, reveals Market Research Future (MRFR) in a detailed research report. The field of wound care biologics includes growth factors, skin substitutes, collagen dressings, etc. which assist in creating an active healing environment for the healing of wounds naturally.

Various factors have been instrumental in shaping the growth of the global wound care biologics market. Among them, rising incidences of burn injuries constitute for a major factor. Wound care biologics are gaining popularity as a treatment modality for the management of burn injuries where there is insufficient skin for grafting. Wound care biologics can provide temporary or permanent coverage of burn wounds, with the advantage of availability in large quantities and little or no risk of immunologic issues or infection.

Rapid growth in the global geriatric population acts as a fuel for the growth of the global wound care biologics market. The rapid growth in the geriatric population will raise the incidences of chronic wounds which would consequently boost the demand for wound care biologics product.

Rising prevalence of diabetic foot ulcers has contributed significantly to the growth of the global wound care biologics market. Global prevalence of diabetes augments the chances of patients developing diabetic ulcers which can have severe implications if untreated.

Raising awareness regarding the availability of wound care biologics, rising standards of livings and greater affordability further supports the growth of the market.

Innovations such as PDGF, RegranexTM, MicroRNA-based therapeutics, small molecule antagonists, use of biomarkers, and VEGF- and GM-CSF-based cosmeceuticals in the field of wound care biologics spurred the growth of the market. However, such as options are associated with high failure rate, and there remain large unmet needs for new effective treatments for acute wounds which are likely to restrain the growth of the market over the forecast period. High costs of wound care biologics and stringent regulatory norms for approval remain major hurdles for the growth of the global wound care biologics market. Meanwhile, improving reimbursement policies is expected to provide growth opportunities to the market over the forecast period.

Segmentation

The global wound care biologics market has been segmented based on product type, wound type, and end user.

By product type, the market has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment was the largest as well as the fastest growing segment in 2017.

By wound type, the market has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.

By end user, the market has been segmented into hospitals, ambulatory surgical centers, and clinics.

Browse Complete Report : https://www.marketresearchfuture.com/reports/wound-care-biologics-market-6563

 

Regional Analysis

The Americas, Europe, Asia-Pacific, and the Middle East & Africa are the key markets for wound care biologics. The Americas dominate the global wound care biologics market, the US and Canada being the key contributors to the Americas market. Robust healthcare sector, growing prevalence of diabetes, rising incidences of accidents and high healthcare expenditure support the growth of the Americas market for wound care biologics.

Europe accounts for the second largest share of the market on account of growing prevalence of chronic diseases and burns cases in the region.

Asia Pacific market is touted to be the fastest growing market for wound care biologics. Presence of a large base of the diabetic population and advances in the healthcare sector contribute to the growth of the market.

The Middle East & Africa market is expected to exhibit sluggish growth owing to the limited availability of healthcare facilities and lack of affordability and awareness.

Competitive Landscape

Some of the major players in the global wound care biologics market include Solsys Medical (US), ACell (US), Organogenesis (US), Anika Therapeutics (US), Integra LifeSciences Corporation (US), MiMedx Group (US), Kerecis (Iceland), Vericel Corporation (US), Marine Polymer Technologies, Inc. (US), Wright Medical (US), Mölnlycke Health Care AB (Sweden), Osiris Therapeutics (US), and Smith & Nephew (UK)